Story perspectives

Study Questions Cost-Effectiveness of Childhood Cholesterol Screening

11/10/2025

50 11

Summary

Story summary

The modeling study evaluated the cost-effectiveness of screening 4.2 million U.S. children for familial hypercholesterolemia (FH) and found screening starting at ages 10 or 18 is not cost-effective.
Although screening could reduce lifetime cardiovascular events, costs are high, estimated at $320 million to $570 million for childhood screening.
The U.S. Preventive Services Task Force has not endorsed childhood lipid screening due to insufficient evidence, while some organizations advocate for it.

1 of 1

Story summary

The modeling study evaluated the cost-effectiveness of screening 4.2 million U.S. children for familial hypercholesterolemia (FH) and found screening starting at ages 10 or 18 is not cost-effective.
Although screening could reduce lifetime cardiovascular events, costs are high, estimated at $320 million to $570 million for childhood screening.
The U.S. Preventive Services Task Force has not endorsed childhood lipid screening due to insufficient evidence, while some organizations advocate for it.